Pharmabroker Mieczkowski sp. k. (Poland)

Main Activities: Administrative Management and General Management Consulting Services

Secondary Activities: Wholesale Trade Agents and Brokers | Data Processing, Hosting, and Related Services | Internet Publishing and Broadcasting and Web Search Portals | Lessors of Real Estate | Advertising Agencies | Marketing Research and Public Opinion Polling | Management of Companies and Enterprises

Full name: Pharmabroker Mieczkowski sp. k.

Profile Updated: June 01, 2025

Pharmabroker Mieczkowski sp. k. is an enterprise located in Poland, with the main office in Warsaw. The enterprise operates in the Administrative Management and General Management Consulting Services industry. Pharmabroker Mieczkowski sp. k. was incorporated on February 07, 2018. A growth of 12.65% was recorded in its total assets.

Headquarters
Ul. Zajecza 15
Warsaw; Mazowieckie; Postal Code: 00-351

Contact Details: Purchase the Pharmabroker Mieczkowski sp. k. report to view the information.

Basic Information

Financial Auditors:

Purchase the Pharmabroker Mieczkowski sp. k. report to view the information.

Incorporation Date:

February 07, 2018

Key Executives

Purchase this report to view the information.

Associate Partner

Purchase this report to view the information.

Associate Partner

Purchase this report to view the information.

Limited Partner

Company Performance

Financial values in the chart are available after Pharmabroker Mieczkowski sp. k. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Total Operating Revenue

582.63%▲

Operating Profit

N/A

EBITDA

N/A

Net Profit/Loss for the Period

N/A

Total Assets

12.65%▲

Total Equity

8.48%▲

Return on Equity (ROE)

N/A

Quick Ratio

0.03%▲

Cash Ratio

0.02%▲

Similar companies